Microsoft Corporation (NASDAQ MSFT) will show off its Windows 9 Technical Preview at a media event in San Francisco on September 30. It will be a litmus test for the software giant. The company hopes that Windows 9 will be able to win back customers Windows 8 had alienated. Windows 8 tarnished the reputation of…
Apple Inc (NASDAQ AAPL) has responded swiftly to the firestorm of reports about the iPhone 6 Plus bending in owners’ pockets. Dubbed “Bendgate” by the media, the issue involves multiple reports and photos from iPhone 6 Plus owners who said their new phone bent while just riding around in their pockets all day. Apple Inc….
Facebook Inc (NASDAQ FB) and Internet.org plans to use drones, to provide internet access to the people still not online, is not new. Facebook Connectivity Lab revealed its plans for the first time in March, and now more details have been provided by engineering director at Facebook Connectivity Lab, Yael Maguire at the 2014 Social…
As the “Internet of Things,” a societal revolution that will connect smart household appliances with cars, cell phones and a master home operating system, becomes more reality than fantasy, a fight to rule this world could emerge between two major players: Google Inc (NASDAQ GOOG) and Apple Inc (NASDAQ AAPL). In a recent interview on…
Shares of Gilead Sciences (GILD) declined approximately 0.9% to close the trading session on Sep 17 at $103.84 following a couple of setbacks — the failure of an oncology candidate to meet the primary endpoint in a phase II study and highly concerning data on the company’s blockbuster hepatitis C drug Sovaldi. Gilead’s pipeline candidate…
The HealthCare segment at Bayer (BAYRY) announced that its blockbuster eye treatment, Eylea, was approved for yet another indication in Japan. The drug was approved by the Ministry of Health, Labour and Welfare (MHLW) in Japan for the treatment of myopic choroidal neovascularization (myopic CNV). Eylea’s approval in the myopic CNV indication was based on…
